Myogenic-induced mesenchymal stem cells are capable of modulating the immune response by regulatory T cells

Pretransplant Infusion of Mesenchymal Stem Cells Prolongs the Survival of a Semiallogeneic Heart Transplant through the Generation of Regulatory T Cells

(2014) F. Casiraghi et al.   JOURNAL OF IMMUNOLOGY

Human amniotic fluid stem cell injection therapy for urethral sphincter regeneration in an animal model

(2012) Bum Soo Kim et al.   BMC Medicine

Cell Therapy for Heart Disease

(2011) Muzammil Mushtaq et al.   CIRCULATION RESEARCH

Long-term Engraftment of Multipotent Mesenchymal Stromal Cells That Differentiate to Form Myogenic Cells in Dogs With Duchenne Muscular Dystrophy

(2011) Yuko Nitahara-Kasahara et al.   MOLECULAR THERAPY

5-Aza-2′-deoxycytidine treatment induces skeletal myogenic differentiation of mouse dental pulp stem cells

(2010) Ryusuke Nakatsuka et al.   ARCHIVES OF ORAL BIOLOGY

Mesenchymal stromal cells inhibit graft-versus-host disease of mice in a dose-dependent manner

(2010) Sun-Young Joo et al.   CYTOTHERAPY

In vitro Myogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells as a Potential Treatment for Urethral Sphincter Muscle Repair

(2009) Adriana C. Drost et al.   Annals of the New York Academy of Sciences

Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis

(2009) E Gonzalez-Rey et al.   ANNALS OF THE RHEUMATIC DISEASES

Kinetics of Th1/Th2 cytokines and lymphocyte subsets to predict chronic GVHD after allo-SCT: results of a prospective study

(2009) C Skert et al.   BONE MARROW TRANSPLANTATION

Mesenchymal stem cells as anti-inflammatories: Implications for treatment of Duchenne muscular dystrophy

(2009) Thomas E. Ichim et al.   CELLULAR IMMUNOLOGY

Cell contact, prostaglandin E2and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25Highforkhead box P3+regulatory T cells

(2009) K. English et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Pharmaceutical and Cellular Strategies in Prophylaxis and Treatment of Graft-Versus-Host Disease

(2009) D. Wolff et al.   CURRENT PHARMACEUTICAL DESIGN

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

(2009) Pierre Fenaux et al.   LANCET ONCOLOGY

Mesenchymal Stem Cells: Emerging Therapy for Duchenne Muscular Dystrophy

(2009) Chad D. Markert et al.   PM&R

Mesenchymal Stem Cells Inhibit the Differentiation of CD4+ T Cells into Interleukin-17-Secreting T Cells

(2008) Eunsil Ko et al.   ACTA HAEMATOLOGICA

Current status of epigenetic treatment in myelodysplastic syndromes

(2008) Andrea Kuendgen et al.   ANNALS OF HEMATOLOGY

Mechanisms of T regulatory cell function

(2008) Nadir Askenasy et al.   AUTOIMMUNITY REVIEWS

The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function

(2008) Rajesh Ramasamy et al.   CELLULAR IMMUNOLOGY

Mesenchymal cells recruit and regulate T regulatory cells

(2008) M DIIANNI   EXPERIMENTAL HEMATOLOGY

The DNA demethylating agent 5-aza-2′-deoxycytidine activates NY-ESO-1 antigenicity in orthotopic human glioma

(2008) Atsushi Natsume et al.   INTERNATIONAL JOURNAL OF CANCER

Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 production

(2008) Krisztián Németh et al.   NATURE MEDICINE

Murine mesenchymal stem cells suppress dendritic cell migration, maturation and antigen presentation

(2007) Karen English et al.   IMMUNOLOGY LETTERS